News

Fierce Pharma11h
Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in head and neck cancer subtype
Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...
Medscape11h
FDA Approves Penpulimab for Nasopharyngeal Cancer
Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...
Defining Personhood, The Next Phase In The Fight For Reproductive Rights
It's been three years since Roe v. Wade was overturned by the Supreme Court.The abortion access landscape has changed dramatically in that time. The procedure has been banned in 12 states with limited ...
Contract Pharma13h
FDA Approves Akeso’s Penpulimab for Nasopharyngeal Carcinoma
The FDA has approved Akeso Inc.’s penpulimab-kcqx in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic NPC.
bne IntelliNews on MSN13h
Panama’s Mulino rules out mining law in bid to restart First Quantum project
By Alek Buttermann Panama’s President José Raúl Mulino has signalled a firm shift in strategy for the future of the country’s ...